Literature DB >> 7461028

Prednisolone concentrations in plasma, saliva and urine.

J Chakraborty, M Hayes, J English, M Baylis, V Marks.   

Abstract

Prednisolone was measured in plasma, saliva and urine at various times after a single dose. Peak plasma prednisolone levels were observed about 1 h after the dose. Saliva prednisolone levels were measurable for at least 3 h after dosing but showed no consistent relationship to either total or free plasma prednisolone concentrations. Unchanged prednisolone in amounts up to 14% of the dose administered was found in the 24 h urine and most of it was excreted in the first 5 h.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7461028     DOI: 10.1007/bf00558389

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  Relationship between digoxin concentrations in serum and saliva.

Authors:  D H Huffman
Journal:  Clin Pharmacol Ther       Date:  1975-03       Impact factor: 6.875

2.  Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.

Authors:  E S Vesell; G T Passananti; P A Glenwright; B H Dvorchik
Journal:  Clin Pharmacol Ther       Date:  1975-09       Impact factor: 6.875

3.  A radioimmunoassay method for prednisolone: comparison with the competitive protein binding method.

Authors:  J Chakraborty; J English; V Marks; M C Dumasia; D J Chapman
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

4.  Plasma prednisolone levels from enteric and non-enteric coated tablets estimated by an original technique.

Authors:  P J Morrison; I D Bradbrook; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

5.  Pharmacokinetics of tolbutamide: prediction by concentration in saliva.

Authors:  S B Matin; S H Wan; J H Karam
Journal:  Clin Pharmacol Ther       Date:  1974-12       Impact factor: 6.875

6.  Radioimmunoassay for prednisolone.

Authors:  W A Colburn; R H Buller
Journal:  Steroids       Date:  1973-06       Impact factor: 2.668

7.  Effectiveness of prednisolone during phenytoin therapy.

Authors:  L B Petereit; A W Meikle
Journal:  Clin Pharmacol Ther       Date:  1977-12       Impact factor: 6.875

8.  Application of salivary salicylate data to biopharmaceutical studies of salicylates.

Authors:  G Graham; M Rowland
Journal:  J Pharm Sci       Date:  1972-08       Impact factor: 3.534

9.  Prednisolone absorption in acute colitis.

Authors:  P R Elliott; J Powell-Tuck; P E Gillespie; J M Laidlow; J E Lennard-Jones; J English; J Chakraborty; V Marks
Journal:  Gut       Date:  1980-01       Impact factor: 23.059

10.  Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.

Authors:  L W Powell; E Axelsen
Journal:  Gut       Date:  1972-09       Impact factor: 23.059

View more
  3 in total

1.  Comparative study of availability of prednisolone after intestinal infusion of prednisolone metasulfobenzoate and prednisone.

Authors:  C Rollin; O Chosidow; B Diquet; C Dutreuil; S Herson; J Revuz; J C Delchier
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

2.  Plasma prednisolone studies in rheumatic patients.

Authors:  M Hayes; A F Alam; F E Bruckner; S M Doherty; A Myles; J English; V Marks; J Chakraborty
Journal:  Ann Rheum Dis       Date:  1983-04       Impact factor: 19.103

3.  Plasma prednisolone measurements in renal transplant patients.

Authors:  J Chakraborty
Journal:  Ulster Med J       Date:  1981
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.